N-(5-tert-butyl-1,2-oxazol-3-yl)-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-1,4-diazepane-1-carboxylate;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]piperazine-1-carboxylate;N-[1-(4-chlorophenyl)ethyl]-N-methyl-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;1,4-diazepan-1-yl-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]methanone;molecular hydrogen

C120H153ClN24O20S5 — CID 158160361

IUPACN-(5-tert-butyl-1,2-oxazol-3-yl)-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-1,4-diazepane-1-carboxylate;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]piperazine-1-carboxylate;N-[1-(4-chlorophenyl)ethyl]-N-methyl-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;1,4-diazepan-1-yl-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]methanone;molecular hydrogen
SMILESCC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]cc(C(=O)N4CCCN(C(=O)OC(C)(C)C)CC4)c3n2)cc1.CC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]cc(C(=O)N4CCCNCC4)c3n2)cc1.CC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]cc(C(=O)N4CCN(C(=O)OC(C)(C)C)CC4)c3n2)cc1.CC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]cc(C(=O)Nc4cc(C(C)(C)C)on4)c3n2)cc1.CC(c1ccc(Cl)cc1)N(C)C(=O)c1c[nH]c2ncc(-c3ccc(S(=O)(=O)C(C)C)cc3)nc12.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C26H33N5O5S.C25H25ClN4O3S.C25H31N5O5S.C23H25N5O4S.C21H25N5O3S.7H2/c1-17(2)37(34,35)19-9-7-18(8-10-19)21-16-28-23-22(29-21)20(15-27-23)24(32)30-11-6-12-31(14-13-30)25(33)36-26(3,4)5;1-15(2)34(32,33)20-11-7-18(8-12-20)22-14-28-24-23(29-22)21(13-27-24)25(31)30(4)16(3)17-5-9-19(26)10-6-17;1-16(2)36(33,34)18-8-6-17(7-9-18)20-15-27-22-21(28-20)19(14-26-22)23(31)29-10-12-30(13-11-29)24(32)35-25(3,4)5;1-13(2)33(30,31)15-8-6-14(7-9-15)17-12-25-21-20(26-17)16(11-24-21)22(29)27-19-10-18(32-28-19)23(3,4)5;1-14(2)30(28,29)16-6-4-15(5-7-16)18-13-24-20-19(25-18)17(12-23-20)21(27)26-10-3-8-22-9-11-26;;;;;;;/h7-10,15-17H,6,11-14H2,1-5H3,(H,27,28);5-16H,1-4H3,(H,27,28);6-9,14-16H,10-13H2,1-5H3,(H,26,27);6-13H,1-5H3,(H,24,25)(H,27,28,29);4-7,12-14,22H,3,8-11H2,1-2H3,(H,23,24);7*1H
InChIKeyFWESJEUFQSMAPC-UHFFFAOYSA-N
MW2447.48 g/mol
LogP20.99
Rot. Bonds23

About N-(5-tert-butyl-1,2-oxazol-3-yl)-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-1,4-diazepane-1-carboxylate;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]piperazine-1-carboxylate;N-[1-(4-chlorophenyl)ethyl]-N-methyl-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;1,4-diazepan-1-yl-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]methanone;molecular hydrogen

N-(5-tert-butyl-1,2-oxazol-3-yl)-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-1,4-diazepane-1-carboxylate;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]piperazine-1-carboxylate;N-[1-(4-chlorophenyl)ethyl]-N-methyl-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;1,4-diazepan-1-yl-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]methanone;molecular hydrogen (PubChem CID 158160361) has the molecular formula C120H153ClN24O20S5 and a molecular weight of 2447.48 g/mol. Its IUPAC name is N-(5-tert-butyl-1,2-oxazol-3-yl)-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-1,4-diazepane-1-carboxylate;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]piperazine-1-carboxylate;N-[1-(4-chlorophenyl)ethyl]-N-methyl-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;1,4-diazepan-1-yl-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]methanone;molecular hydrogen.

Molecular Properties

Compound NameN-(5-tert-butyl-1,2-oxazol-3-yl)-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-1,4-diazepane-1-carboxylate;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]piperazine-1-carboxylate;N-[1-(4-chlorophenyl)ethyl]-N-methyl-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;1,4-diazepan-1-yl-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]methanone;molecular hydrogen
PubChem CID158160361
Molecular FormulaC120H153ClN24O20S5
Molecular Weight2447.48 g/mol
Exact Mass2445.00
IUPAC NameN-(5-tert-butyl-1,2-oxazol-3-yl)-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-1,4-diazepane-1-carboxylate;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]piperazine-1-carboxylate;N-[1-(4-chlorophenyl)ethyl]-N-methyl-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;1,4-diazepan-1-yl-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]methanone;molecular hydrogen
SMILESCC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]cc(C(=O)N4CCCN(C(=O)OC(C)(C)C)CC4)c3n2)cc1.CC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]cc(C(=O)N4CCCNCC4)c3n2)cc1.CC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]cc(C(=O)N4CCN(C(=O)OC(C)(C)C)CC4)c3n2)cc1.CC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]cc(C(=O)Nc4cc(C(C)(C)C)on4)c3n2)cc1.CC(c1ccc(Cl)cc1)N(C)C(=O)c1c[nH]c2ncc(-c3ccc(S(=O)(=O)C(C)C)cc3)nc12.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C26H33N5O5S.C25H25ClN4O3S.C25H31N5O5S.C23H25N5O4S.C21H25N5O3S.7H2/c1-17(2)37(34,35)19-9-7-18(8-10-19)21-16-28-23-22(29-21)20(15-27-23)24(32)30-11-6-12-31(14-13-30)25(33)36-26(3,4)5;1-15(2)34(32,33)20-11-7-18(8-12-20)22-14-28-24-23(29-22)21(13-27-24)25(31)30(4)16(3)17-5-9-19(26)10-6-17;1-16(2)36(33,34)18-8-6-17(7-9-18)20-15-27-22-21(28-20)19(14-26-22)23(31)29-10-12-30(13-11-29)24(32)35-25(3,4)5;1-13(2)33(30,31)15-8-6-14(7-9-15)17-12-25-21-20(26-17)16(11-24-21)22(29)27-19-10-18(32-28-19)23(3,4)5;1-14(2)30(28,29)16-6-4-15(5-7-16)18-13-24-20-19(25-18)17(12-23-20)21(27)26-10-3-8-22-9-11-26;;;;;;;/h7-10,15-17H,6,11-14H2,1-5H3,(H,27,28);5-16H,1-4H3,(H,27,28);6-9,14-16H,10-13H2,1-5H3,(H,26,27);6-13H,1-5H3,(H,24,25)(H,27,28,29);4-7,12-14,22H,3,8-11H2,1-2H3,(H,23,24);7*1H
InChIKeyFWESJEUFQSMAPC-UHFFFAOYSA-N
XLogP20.99
TPSA586.03 Ų
H-Bond Donors7
H-Bond Acceptors32
Rotatable Bonds23
Heavy Atoms170
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002447.48
LogP ≤ 520.99
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1032

Analyze N-(5-tert-butyl-1,2-oxazol-3-yl)-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-1,4-diazepane-1-carboxylate;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]piperazine-1-carboxylate;N-[1-(4-chlorophenyl)ethyl]-N-methyl-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;1,4-diazepan-1-yl-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]methanone;molecular hydrogen with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(5-tert-butyl-1,2-oxazol-3-yl)-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-1,4-diazepane-1-carboxylate;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]piperazine-1-carboxylate;N-[1-(4-chlorophenyl)ethyl]-N-methyl-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;1,4-diazepan-1-yl-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]methanone;molecular hydrogen?
The IUPAC name of N-(5-tert-butyl-1,2-oxazol-3-yl)-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-1,4-diazepane-1-carboxylate;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]piperazine-1-carboxylate;N-[1-(4-chlorophenyl)ethyl]-N-methyl-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;1,4-diazepan-1-yl-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]methanone;molecular hydrogen (CID 158160361) is N-(5-tert-butyl-1,2-oxazol-3-yl)-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-1,4-diazepane-1-carboxylate;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]piperazine-1-carboxylate;N-[1-(4-chlorophenyl)ethyl]-N-methyl-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;1,4-diazepan-1-yl-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]methanone;molecular hydrogen.
What is the SMILES notation for N-(5-tert-butyl-1,2-oxazol-3-yl)-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-1,4-diazepane-1-carboxylate;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]piperazine-1-carboxylate;N-[1-(4-chlorophenyl)ethyl]-N-methyl-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;1,4-diazepan-1-yl-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]methanone;molecular hydrogen?
The canonical SMILES for N-(5-tert-butyl-1,2-oxazol-3-yl)-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-1,4-diazepane-1-carboxylate;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]piperazine-1-carboxylate;N-[1-(4-chlorophenyl)ethyl]-N-methyl-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;1,4-diazepan-1-yl-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]methanone;molecular hydrogen is CC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]cc(C(=O)N4CCCN(C(=O)OC(C)(C)C)CC4)c3n2)cc1.CC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]cc(C(=O)N4CCCNCC4)c3n2)cc1.CC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]cc(C(=O)N4CCN(C(=O)OC(C)(C)C)CC4)c3n2)cc1.CC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]cc(C(=O)Nc4cc(C(C)(C)C)on4)c3n2)cc1.CC(c1ccc(Cl)cc1)N(C)C(=O)c1c[nH]c2ncc(-c3ccc(S(=O)(=O)C(C)C)cc3)nc12.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].
What is the InChIKey of N-(5-tert-butyl-1,2-oxazol-3-yl)-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-1,4-diazepane-1-carboxylate;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]piperazine-1-carboxylate;N-[1-(4-chlorophenyl)ethyl]-N-methyl-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;1,4-diazepan-1-yl-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]methanone;molecular hydrogen?
The InChIKey is FWESJEUFQSMAPC-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H33N5O5S.C25H25ClN4O3S.C25H31N5O5S.C23H25N5O4S.C21H25N5O3S.7H2/c1-17(2)37(34,35)19-9-7-18(8-10-19)21-16-28-23-22(29-21)20(15-27-23)24(32)30-11-6-12-31(14-13-30)25(33)36-26(3,4)5;1-15(2)34(32,33)20-11-7-18(8-12-20)22-14-28-24-23(29-22)21(13-27-24)25(31)30(4)16(3)17-5-9-19(26)10-6-17;1-16(2)36(33,34)18-8-6-17(7-9-18)20-15-27-22-21(28-20)19(14-26-22)23(31)29-10-12-30(13-11-29)24(32)35-25(3,4)5;1-13(2)33(30,31)15-8-6-14(7-9-15)17-12-25-21-20(26-17)16(11-24-21)22(29)27-19-10-18(32-28-19)23(3,4)5;1-14(2)30(28,29)16-6-4-15(5-7-16)18-13-24-20-19(25-18)17(12-23-20)21(27)26-10-3-8-22-9-11-26;;;;;;;/h7-10,15-17H,6,11-14H2,1-5H3,(H,27,28);5-16H,1-4H3,(H,27,28);6-9,14-16H,10-13H2,1-5H3,(H,26,27);6-13H,1-5H3,(H,24,25)(H,27,28,29);4-7,12-14,22H,3,8-11H2,1-2H3,(H,23,24);7*1H.
What are the key properties of N-(5-tert-butyl-1,2-oxazol-3-yl)-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-1,4-diazepane-1-carboxylate;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]piperazine-1-carboxylate;N-[1-(4-chlorophenyl)ethyl]-N-methyl-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;1,4-diazepan-1-yl-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]methanone;molecular hydrogen?
N-(5-tert-butyl-1,2-oxazol-3-yl)-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-1,4-diazepane-1-carboxylate;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]piperazine-1-carboxylate;N-[1-(4-chlorophenyl)ethyl]-N-methyl-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;1,4-diazepan-1-yl-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]methanone;molecular hydrogen has a molecular weight of 2447.48 g/mol, XLogP of 20.99, 23 rotatable bonds, 7 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-tert-butyl-1,2-oxazol-3-yl)-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-1,4-diazepane-1-carboxylate;tert-butyl 4-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]piperazine-1-carboxylate;N-[1-(4-chlorophenyl)ethyl]-N-methyl-2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide;1,4-diazepan-1-yl-[2-(4-propan-2-ylsulfonylphenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]methanone;molecular hydrogen is sourced from PubChem (CID 158160361), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).